Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
With Child Deaths Projected to Rise for the First Time in a Century, Gates Foundation and Mohamed Bin Zayed Foundation for Humanity Urge Action as World Faces Critical Turning Point
At Goalkeepers Abu Dhabi, global leaders outline a path to improve and…
Ipsen – November 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing…
Abstract and Open World Partner to Launch the First National-Scale Tokenization Engine for the World’s Most Valuable Real-World Assets
For the first time, the world's most strategic assets—AI supercomputing centers, strategic…
VELO AND THE McLAREN FORMULA 1 TEAM’S FAN-DESIGNED LIVERY TAKES CENTRE STAGE AS LANDO NORRIS WINS 2025 DRIVERS’ CHAMPIONSHIP IN ABU DHABI
ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- Yesterday, the McLaren Formula 1®…
The Acceleration Continues: Vetty Named One of Nucleus Researchs Hot Companies to Watch in 2026
AUSTIN, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Vetty, the one-stop shop…
Global Stars Confirmed as the Games of the Future Abu Dhabi 2025 Finalises Full Line-Up
Some of the biggest names in phygital sports and esports from around…
The 4th China International Supply Chain Expo Set for Beijing in June 2026
Sustained Worldwide Outreach Drives Greater Collaboration OpportunitiesBEIJING, Dec. 7, 2025 /PRNewswire/ -- …
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
93% overall response and 76% complete response rates with median progression-free survival…
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
December 07, 2025 16:00 ET | Source: Wave Life Sciences USA, Inc.…
